{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T07:47:28Z","timestamp":1792223248496,"version":"4.4.0"},"reference-count":44,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2010,1,22]],"date-time":"2010-01-22T00:00:00Z","timestamp":1264118400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Immunology"],"published-print":{"date-parts":[[2010,6]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>We have established <jats:italic>Leishmania tropica<\/jats:italic> as the causative agent of cutaneous leishmaniasis (CL) in the region of India where the disease is endemic. The association between localized and circulating levels of immune\u2010determinants in CL patients was evaluated. Reverse transcription\u2013polymerase chain reaction analysis revealed up\u2010regulation of interferon\u2010\u03b3 (IFN\u2010\u03b3), interleukin (IL)\u20101\u03b2, IL\u20108, tumour necrosis factor\u2010\u03b1 (TNF\u2010\u03b1), IL\u201010 and IL\u20104 in dermal lesions at the pretreatment stage (<jats:italic>n<\/jats:italic>\u2003=\u200331) compared with healthy controls (<jats:italic>P\u2003<\/jats:italic>&lt;<jats:italic>\u2003<\/jats:italic>0\u00b7001) and a significant down\u2010regulation after treatment (<jats:italic>n<\/jats:italic>\u2003=\u200314, <jats:italic>P\u2003<\/jats:italic>&lt;<jats:italic>\u2003<\/jats:italic>0\u00b705). The results indicated that an unfavourable clinical outcome in CL was not related to an inadequate T helper 1 (Th1) cell response, but rather to impairment in multiple immune functions. Comparative assessment of treatment regimes with rifampicin (RFM) or sodium antimony gluconate (SAG) revealed tissue cytokine levels to be significantly reduced after treatment with RFM (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030\u00b7005), while no significant decrease was evident in the levels of IFN\u2010\u03b3, TNF\u2010\u03b1 and IL\u201010 (<jats:italic>P\u2003<\/jats:italic>&gt;<jats:italic>\u2003<\/jats:italic>0\u00b705) as a result of treatment with SAG. Increased transcripts of monocyte chemoattractant protein\u20101 (MCP\u20101) (<jats:italic>P\u2003<\/jats:italic>&lt;<jats:italic>\u2003<\/jats:italic>0\u00b7001) and inducible nitric oxide synthase (iNOS) (<jats:italic>P\u2003<\/jats:italic>&lt;<jats:italic>\u2003<\/jats:italic>0\u00b705) were evident before treatment in tissue lesions and remained high after treatment. Immunohistochemistry demonstrated strong expression of myeloperoxidase (MPO) and IL\u20108, and moderate expression of iNOS in dermal lesions. The expression levels of IL\u20108, MCP\u20101 and nitric oxide (NO) were high in patient sera before treatment, as determined using cytokine bead array and enzyme\u2010linked immunosorbent assay (ELISA). At the post\u2010treatment stage, the serum IL\u20108 levels had decreased; however, the levels of MCP\u20101 and NO remained high. These data suggest that IL\u20108 is an effector immune\u2010determinant in the progression of CL, whereas NO facilitates the parasite killing by macrophages via MCP\u20101\u2010mediated stimulation.<\/jats:p>","DOI":"10.1111\/j.1365-2567.2009.03223.x","type":"journal-article","created":{"date-parts":[[2010,1,22]],"date-time":"2010-01-22T12:33:13Z","timestamp":1264163593000},"page":"193-201","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Evaluation of localized and systemic immune responses in cutaneous leishmaniasis caused by <i>Leishmania tropica<\/i>: interleukin\u20108, monocyte chemotactic protein\u20101 and nitric oxide are major regulatory factors"],"prefix":"10.1111","volume":"130","author":[{"given":"Rajesh","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram A.","family":"Bumb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poonam","family":"Salotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,5,7]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpara.2005.07.001"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpara.2005.09.010"},{"key":"e_1_2_7_4_2","doi-asserted-by":"crossref","first-page":"896","DOI":"10.4269\/ajtmh.2007.76.896","article-title":"Cutaneous leishmaniasis caused by Leishmania tropica in Bikaner, India: parasite identification and characterization using molecular and immunological tools","volume":"76","author":"Kumar R","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.181.3.961"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0952-7915(98)80121-0"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1993.tb05931.x"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.145.9.3100"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-695X.1996.tb00059.x"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.2.826-835.2002"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004300100084"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3024.2002.00467.x"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/150.1.135"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.6.4090"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3083.2003.01227.x"},{"key":"e_1_2_7_16_2","first-page":"1631","article-title":"Differential chemokine regulation by Th2 cytokines during human RPE\u2013monocyte coculture","volume":"42","author":"Yoshida A","year":"2001","journal-title":"Invest Ophth Vis Sci"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.142.8.3537"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0162-3109(94)90017-5"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1086\/506624"},{"key":"e_1_2_7_20_2","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.4049\/jimmunol.145.12.4306","article-title":"Tumor necrosis factor\u2010alpha synergizes with IFN\u2010gamma in mediating killing of Leishmania major through the induction of nitric oxide","volume":"145","author":"Liew FY","year":"1990","journal-title":"J Immunol"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.1989.tb00552.x"},{"key":"e_1_2_7_22_2","first-page":"103","article-title":"Serum levels of tumour necrosis factor\u2010alpha and interleukin\u20101 beta during leprosy reactional states","volume":"84","author":"Sarno EN","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1086\/515297"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.16.7011"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)90416-E"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830200938"},{"key":"e_1_2_7_27_2","first-page":"4297","article-title":"Interleukin\u20108 is produced in neoplastic and infectious diseases of the human central nervous system","volume":"52","author":"Van Mier E","year":"1992","journal-title":"Cancer Res"},{"key":"e_1_2_7_28_2","doi-asserted-by":"crossref","first-page":"22506","DOI":"10.1016\/S0021-9258(18)41701-2","article-title":"Tumor necrosis factor alpha and interferon gamma synergistically induce interleukin 8 production in a human gastric cancer cell line through acting concurrently on AP\u20101 and NF\u2010\u03baB\u2010like binding sites of the interleukin 8 gene","volume":"267","author":"Yasumoto K","year":"1992","journal-title":"J Biol Chem"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.169.2.898"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.8.4177-4184.2002"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.5.2628"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-2427(96)05562-6"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.2.969"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.152.6.2930"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/1521-4141(200011)30:11<3111::AID-IMMU3111>3.0.CO;2-O"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/173.3.699"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-695X.2009.00607.x"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80342-8"},{"key":"e_1_2_7_39_2","doi-asserted-by":"crossref","first-page":"890","DOI":"10.4049\/jimmunol.141.3.890","article-title":"Regulation of activated macrophage antimicrobial activities. Identification of lymphokines that cooprate with IFN\u2010gamma for induction of resistance to infection","volume":"141","author":"Belosevic M","year":"1988","journal-title":"J Immunol"},{"key":"e_1_2_7_40_2","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1128\/iai.65.8.3225-3230.1997","article-title":"Successful therapy of chronic, non\u2010healing murine cutaneous leishmaniasis with sodium stibogluconate and gamma interferon depends on continued interleukin\u201012 production","volume":"65","author":"Li J","year":"1997","journal-title":"Infect Immun"},{"key":"e_1_2_7_41_2","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.4049\/jimmunol.160.9.4143","article-title":"Mice defective in Fas are highly susceptible to Leishmania major infection despite elevated IL\u201012 synthesis, strong Th1 responses, and enhanced nitric oxide production","volume":"160","author":"Haung FP","year":"1998","journal-title":"J Immunol"},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.1086\/340820"},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.12.6589-6591.2002"},{"key":"e_1_2_7_44_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/49.3.531"},{"key":"e_1_2_7_45_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.50.1.396-398.2006"}],"container-title":["Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2567.2009.03223.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2567.2009.03223.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T01:31:59Z","timestamp":1698629519000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2567.2009.03223.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,7]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["10.1111\/j.1365-2567.2009.03223.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2567.2009.03223.x","archive":["Portico"],"relation":{},"ISSN":["0019-2805","1365-2567"],"issn-type":[{"value":"0019-2805","type":"print"},{"value":"1365-2567","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,7]]},"assertion":[{"value":"2010-05-07","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}